NeuroFlow Behavioral Health Analytics Platform
Holistic data analysis platform that surfaces hidden behavioral health risk in populations
Platform · Cloud SaaSCompany source
Company profile
About NeuroFlow
NeuroFlow is a behavioral health data analytics and care management platform that empowers health plans, health systems, ACOs, IDNs, federal government agencies, and behavioral health providers to identify and manage behavioral health risk at scale. The company addresses the costly blind spot of behavioral health by providing infrastructure and analytics that make risk more predictable and transparent, improving outcomes and cost control. The platform surfaces hidden behavioral health risk across populations using transparent machine learning on claims, EHR, ADT, and assessment data. NeuroFlow enables organizations to identify population cohorts with likely behavioral health needs, stratify by acuity, engage patients through remote assessments, and connect them to appropriate benefits and providers through seamless referral flows. The solution includes measurement-informed care tools that monitor patient progress and support clinical decision-making. NeuroFlow has collected over 6.61 million health assessments and surveys, identified 55,000 instances of suicidal ideation and rising risk, and saves clinicians an average of 6.5 minutes per visit through remote assessments. The company serves leading healthcare organizations including Independence Blue Cross, Atlantic Health System, Emory Healthcare, and Intermountain Health. Partners use NeuroFlow to understand behavioral health risk, engage and route patients at scale, and demonstrate measurable impact through longitudinal outcome tracking for pay-for-performance programs and quality measures.
Company description NeuroFlow official website
Primary marketMental Health & Digital Therapeutics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at NeuroFlow?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Anxiety
- Co-occurring conditions
- Delirium
- Depression
- General behavioral health conditions
- Opioid use disorder
- Panic disorder
- Suicidal ideation
Who it serves
- ACOs
- Behavioral Health Providers
- Federal Government
- Health Plans
- Health Systems
- IDNs
- Payers
Deployment & integration
Cloud Saas deployment with recorded integration context.
Recorded integration context: ADT (Admission/Discharge/Transfer) systems, Claims data, EHR.
Geographic context
MarketsUnited States
Company sourceOfficial website
Company milestones
Platform expansion
Partnership with Independence Blue Cross to improve behavioral health access and lower costs, expansion of referral network with multiple behavioral health providers
Partnerships
Recorded partners
- Carelon Behavioral Health
- Headway
- LifeStance Health
- Mindpath Health
- Monument
- Ophelia
- Talkspace
- Thriveworks
- Various telehealth and behavioral health providers in referral network
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
NeuroFlow Clinical Decision Support Platform
AI-powered triage engine for behavioral health risk stratification and care routing
Platform · Cloud SaaSCompany source
NeuroFlow Referral Network
Clinical partner network connecting patients to appropriate behavioral health providers
Platform · Cloud SaaSCompany source
NeuroFlow Self-Care Application
Patient engagement platform for self-guided behavioral health support
Software · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Implementing Digital Suicide Risk Screening in Behavioral Health: a Mixed-methods Study of Organizational Adaptation.Community mental health journal · May 2, 2026
Evaluating Generative Pretrained Transformer (GPT) models for suicide risk assessment in synthetic patient journal entries.BMC psychiatry · Aug 1, 2025
mHealth-Augmented Care for Reducing Depression Symptom Severity Among Patients With Chronic Pain: Exploratory, Retrospective Cohort Study.JMIR mHealth and uHealth · Jan 10, 2025
Technology-enabled Behavioral Health Integration Decreases Emergency Department Utilization.Clinical practice and epidemiology in mental health : CP & EMH · Jan 1, 2022
Development of a Severity Score and Comparison With Validated Measures for Depression and Anxiety: Validation Study.JMIR formative research · Nov 10, 2021
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
14x increase in behavioral health screening rates
Medical center case study with 3x ROI
$28 PMPM reduction in total care costs
Independence Blue Cross through reduced ED visits and inpatient hospitalization
34% reduction in ED utilization
Jefferson Health with digital behavioral health integration
6.5 minutes clinician time saved per visit
Due to remote assessments
124% increase in DCBT program registrations
Magellan Health compared to previous programs
19% of claimants with unidentified mental wellness needs
Prudential disability claimants
55,000 instances of suicidal ideation identified
Across platform usage
6.61 million health assessments collected
Total platform data collection
Atlantic Health System
Identify and prioritize behavioral health concerns, collect whole-person data, and support management with clinical decision insights
Increased behavioral health screening rates 14x, improved P4P revenue with 3x return on NeuroFlow investment
Emory Healthcare
Expand and enhance collaborative integrated care throughout the Emory ecosystem
Improved outcomes and reduced costs through enhanced integrated care
Independence Blue Cross
Increase behavioral health access and reduce emergency department visits and inpatient hospitalizations
$28 PMPM reduction in total care costs through lower ED visits and inpatient hospitalization
Intermountain Health
Systematically understand acuity and complexity of behavioral health conditions at scale in primary care
Enabled primary care providers to assess behavioral health needs at scale while removing administrative burden
Jefferson Health
Reduce emergency department utilization through digital behavioral health integration
34% reduction in ED utilization
Magellan Health
Increase registrations in digital cognitive behavioral therapy (DCBT) program
124% increase in DCBT program registrations compared to previous programs
Prudential
Identify previously unidentified mental wellness needs in disability claimants
19% of disability claimants found to have previously unidentified mental wellness needs
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
Christopher Molaro
CEO & Founder
Adam Pardes
President & Co-Founder
Tom Zaubler
Chief Medical Officer
Pete Tantillo
Chief Financial Officer
Shannon Stotenbur
Chief Growth Officer of Government and Public Sector
Michael Mucha
Chief Commercial Growth Officer
Jen McClintic
Senior Vice President of People
Jennie Shulkin
Senior Vice President of Legal & Strategy
06 · Company updates
Updates from NeuroFlow
Recent articles published on NeuroFlow's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Mental Health & Digital Therapeutics
Companies providing AI-powered mental health support, therapy platforms, mental wellness tracking, psychiatric care, digital therapeutics for mental health conditions, or AI-driven mental health screening and monitoring. Includes XR-based therapy, AI mental health screening infrastructure, and platforms supporting behavioral health for individuals and health systems.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.